Patent details

Basic Information

Publication number:

EP0351733

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP891129595

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders.

French Title of Invention:

Utilisation de dérivés de 2,3,4,5-tétrahydro-1H-3-benzazépines dans le traitement de troubles neurologiques.

German Title of Invention:

Verwendung von 2,3,4,5-Tetrahydro-1H-3-Benzazepinen bei der Behandlung von neurologischen StÖrungen.

SPC Number:

Dates

Filing date:

14/07/1989

Grant date:

06/12/1995

EP Publication Date:

06/12/1995

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/01/1990

EP B1 Publication Date:

06/12/1995

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/07/1996

Expiration date:

14/07/2009

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/07/1989

 

 

Name:

SCHERING CORPORATION

Address:

GALLOPING HILL ROAD 2000, KENILWORTH NEW JERSEY 07033, United States (US)

Inventor

1

Name:

Berger Joel G.

Address:

United States (US)

2

Name:

Chang Wei K.

Address:

United States (US)

3

Name:

Clader John W.

Address:

United States (US)

4

Name:

Gold Elijah H.

Address:

United States (US)

Priority

Priority Number:

223739

Priority Date:

18/07/1988

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/55;

Filing date	Document type	Number of pages